Understanding and manipulating the T cell contraction phase

了解和操纵 T 细胞收缩期

基本信息

  • 批准号:
    7755373
  • 负责人:
  • 金额:
    $ 46.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Protective immunity, whether induced by infection or by vaccination, relies on the generation of memory B & T cells in sufficient quantity, and of sufficient quality. In the case of CD8+ T cells - to be studied herein - these memory cells usually represent the few survivors of a dramatic and rapid cull, T cell contraction, in which 90-95% of virus specific CD8+ T cells (in our model, ~50 million cells) are removed over a period of 1-2 weeks. The process of T cell contraction remains poorly-understood, and the overall goal of this proposal is to better characterize the causes and consequences of T cell contraction. The application has the following 4 Specific Aims: 1. To investigate the role of direct IFN3 signaling in regulating CD8+ T cell contraction. IFN3 is a key cytokine. Its receptor is expressed on almost all somatic cells, allowing it to act both as an antiviral effector molecule, and as an immunomodulatory molecule. We have developed a novel approach that allows us to evaluate the direct effects of IFN3 on T cells during virus infection, and we have found that - contrary to much of the published literature - the effects of IFN3 are strongly positive; T cells that are unable to receive IFN3 signals during virus infection are 100-fold less likely to enter the memory pool. In this aim, we propose a detailed analysis of these direct effects. 2. To determine how indirect effects of IFN3 affect T cell contraction. The widespread expression of the IFN3 receptor means that IFN3 also can affect T cell biology indirectly, via a multitude of paths. Some of these indirect effects will be evaluated. 3. To evaluate antigen persistence after acute virus infection is cleared, determine its effects on the quality and quantity of T cells, and analyze the role of IFN3 in these effects. Antigen contact plays an important part in regulating T cell function, and we have developed a new approach that allows us to identify T cells that have recently encountered authentic viral antigen in vivo. We shall ask how recent antigen contact correlates with a variety of T cell phenotypes (proliferative status, expression of cytokine receptors, etc.). 4. To manipulate T cell contraction, and determine the consequences on the quantity and quality of memory cells. Most studies suggest that T cell contraction is relatively random, but I propose that it may be selective, possibly serving to separate the wheat from the chaff. To investigate this, various approaches will be taken to modify the contraction phase, and the quantity and quality of the surviving T cells will be determined.
描述(由申请人提供):保护性免疫,无论是通过感染还是通过疫苗接种诱导,都依赖于足够数量和足够质量的记忆B和T细胞的产生。在本文将要研究的CD 8 + T细胞的情况下,这些记忆细胞通常代表了急剧和快速淘汰的少数幸存者,T细胞收缩,其中90-95%的病毒特异性CD 8 + T细胞(在我们的模型中,约5000万个细胞)在1-2周的时间内被去除。T细胞收缩的过程仍然知之甚少,本提案的总体目标是更好地表征T细胞收缩的原因和后果。该应用程序有以下4个具体目标:1。研究IFN 3直接信号转导在调节CD 8 + T细胞收缩中的作用。IFN 3是一种关键的细胞因子。它的受体在几乎所有的体细胞上表达,使其既可以作为抗病毒效应分子,也可以作为免疫调节分子。我们已经开发了一种新的方法,使我们能够评估病毒感染期间IFN 3对T细胞的直接影响,我们发现-与大多数已发表的文献相反-IFN 3的影响是强烈的;在病毒感染期间无法接收IFN 3信号的T细胞进入记忆池的可能性降低了100倍。为此,我们提出了这些直接影响的详细分析。2.确定IFN 3的间接作用如何影响T细胞收缩。IFN 3受体的广泛表达意味着IFN 3也可以通过多种途径间接影响T细胞生物学。将对其中一些间接影响进行评估。3.评估急性病毒感染清除后抗原的持续性,确定其对T细胞质量和数量的影响,并分析IFN 3在这些影响中的作用。抗原接触在调节T细胞功能中起着重要作用,我们已经开发出一种新的方法,使我们能够识别最近在体内遇到真实病毒抗原的T细胞。我们将询问最近的抗原接触如何与各种T细胞表型(增殖状态,细胞因子受体的表达等)相关。4.操纵T细胞收缩,并确定对记忆细胞数量和质量的影响。大多数研究表明,T细胞收缩是相对随机的,但我认为它可能是选择性的,可能有助于区分小麦和谷壳。为了研究这一点,将采取各种方法来修改收缩期,并确定存活T细胞的数量和质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J. Lindsay Whitton其他文献

Host and virus determinants of picornavirus pathogenesis and tropism
小核糖核酸病毒发病机制和嗜性的宿主和病毒决定因素
  • DOI:
    10.1038/nrmicro1284
  • 发表时间:
    2005-10-01
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    J. Lindsay Whitton;Christopher T. Cornell;Ralph Feuer
  • 通讯作者:
    Ralph Feuer
Microorganisms and autoimmunity: making the barren field fertile?
微生物与自身免疫:让贫瘠的领域肥沃起来?
  • DOI:
    10.1038/nrmicro754
  • 发表时间:
    2003-11-01
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    Matthias G. von Herrath;Robert S. Fujinami;J. Lindsay Whitton
  • 通讯作者:
    J. Lindsay Whitton

J. Lindsay Whitton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J. Lindsay Whitton', 18)}}的其他基金

Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    9225171
  • 财政年份:
    2015
  • 资助金额:
    $ 46.9万
  • 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    9027796
  • 财政年份:
    2015
  • 资助金额:
    $ 46.9万
  • 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    8795589
  • 财政年份:
    2015
  • 资助金额:
    $ 46.9万
  • 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
  • 批准号:
    9198190
  • 财政年份:
    2015
  • 资助金额:
    $ 46.9万
  • 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
  • 批准号:
    8997975
  • 财政年份:
    2015
  • 资助金额:
    $ 46.9万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8735569
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
  • 批准号:
    8811097
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
  • 批准号:
    8630094
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8854024
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8894191
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 46.9万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 46.9万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 46.9万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 46.9万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 46.9万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 46.9万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 46.9万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 46.9万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 46.9万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 46.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了